Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$433.03 +0.43 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

Madrigal Pharmaceuticals (MDGL) Return on Equity [ROE] (2009 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) posted Return on Equity [ROE] of -26.38% for Q3 2026, up 16.91 percentage points from -43.29% a year earlier and up 33.42 percentage points from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Madrigal Pharmaceuticals' Return on Equity [ROE] came in at -42.01%, up 38.34 percentage points from FY2024.

  • Annual Return on Equity [ROE] has increased for three consecutive years, with a five-year change of +19.63 percentage points (FY2020 to FY2025).
  • In prior years, Madrigal Pharmaceuticals' Return on Equity [ROE] was -80.35% in FY2024 (+43.63 pp), -123.98% in FY2023 (+26.14 pp), -150.12% in FY2022 (-39.07 pp) and -111.04% in FY2021 (-49.40 pp).
  • The Q3 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q1 2020.
  • On a year-over-year basis, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +22.88 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2024, with a gain of 488.94 percentage points; the weakest was Q3 2022, with a drop of 488.06 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -59.79% (Q2 2026), -53.08% (Q1 2026) and -46.42% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Madrigal Pharmaceuticals 12.65 Bn 9.06 Bn 393.45 Mn -26.38%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -26.38%
Jun 30, 2026 -59.79%
Mar 31, 2026 -53.08%
Dec 31, 2025 -46.42%
Sep 30, 2025 -43.29%
Jun 30, 2025 -40.08%
Mar 31, 2025 -53.46%
Dec 31, 2024 -60.84%
Sep 30, 2024 -63.47%
Jun 30, 2024 -59.78%
Mar 31, 2024 -70.74%
Dec 31, 2023 -174.76%
Sep 30, 2023 -552.41%
Jun 30, 2023 -260.05%
Mar 31, 2023 -181.13%
Dec 31, 2022 -283.91%
Sep 30, 2022 -581.70%
Jun 30, 2022 -223.22%
Mar 31, 2022 -144.40%
Dec 31, 2021 -112.36%
API Access

Madrigal Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MDGL&period=max&api_key=YOUR_API_KEY